CVE Tools

CVE-2026-12647

No known exploitation. EPSS puts it in the 75th percentile. Fixed in 2026.2.

Check it yourself

OpenVAS · 1 check

e.g. OID 1.3.6.1.4.1.25623.1.0.157874

Run the check

Published Updated Sources: CVE.org, NVD

What to do

Find your product and version, then upgrade to the build on the right.

  • Ivanti Neurons for ITSMFixed builds2026.2Stated by: CVE record

Versions as the sources state them. Full version matrix after sign-in

Steps

Written by AI from the record
  1. Check your Ivanti Neurons for ITSM version number and confirm whether it is earlier than 2026.2.
  2. If you are on a version before 2026.2, schedule an urgent upgrade to Ivanti Neurons for ITSM 2026.2.
  3. After upgrading, verify the new version is actually running and that remote administration endpoints (if any) are only reachable from trusted networks.
  4. Review authentication logs for low-privilege logins from remote IPs around the last configuration/changes, and investigate anything unusual.

What it is

From the CVE record

A Missing Authorization vulnerability in Ivanti Neurons for ITSM before 2026.2 allows a remote authenticated attacker to execute arbitrary code on the server.

In plain language

Written by AI from the record

CVE-2026-12647 is a serious break-in risk in Ivanti Neurons for ITSM: if someone logs in with low privileges, they may be able to run commands and take control of your server remotely. If you use Ivanti Neurons for ITSM, you should act now and upgrade to 2026.2 or later.

Missing Authorization in Ivanti Neurons for ITSM before 2026.2 allows a remote authenticated attacker with low privileges to bypass access controls and execute arbitrary code on the server via a network-accessible action without user interaction.

If you're affected

  • Full server takeover
  • Customer/support data exposure
  • Service outage and downtime
  • Malware installation and persistence

Exploitation

Where each signal puts this CVE on the scale from published to confirmed exploited.

EPSS75th
CISA KEV

Not in the catalog. CISA has not confirmed exploitation.

Public exploits

No public exploit or proof of concept found in the sources we track.

EPSS

1.5% chance of exploitation activity in the next 30 days, which ranks it in the 75th percentile of scored CVEs.

Exploit Prediction Scoring System, FIRST.org. A probability, not a confirmation.

Lifecycle

9 events over 10 days, from the signal feeds we watch.

  1. Patch availablerecord updated
  2. OpenVAS check added
  3. Record updated
  4. Publishedweakness classified, att&ck mapped, record updated, record updated

Affected products

Technical detail

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

Scored 9.9 by NVD.

How it is reached

  • Attack Vector NetworkExploitable remotely over the network without any special conditions
  • Attack Complexity LowNo special conditions — the attack can be reliably reproduced
  • Privileges Required LowRequires basic user-level privileges
  • User Interaction NoneNo user interaction needed — fully automated exploitation

Scope

  • Scope ChangedThe exploit can affect other components (e.g. sandbox escape, host compromise from VM)

Impact if exploited

  • Confidentiality HighTotal information disclosure — all data in the component is compromised
  • Integrity HighTotal loss of integrity — attacker can modify any data in the component
  • Availability HighTotal denial of service — the component is completely unavailable

Weaknesses

ATT&CK techniques

Mapped from the weaknesses above (CWE to ATT&CK), not observed in attacks.

Sources

Watch the software you run.

My Stack ranks new CVEs for your products by real-world exploitation, so the next serious one reaches you without reading every advisory.

We'll flag the next CVE, public exploit or patch for Ivanti Neurons for ITSM, not every advisory.